{"id":611444,"date":"2026-09-02T16:39:32","date_gmt":"2026-09-02T16:39:32","guid":{"rendered":"https:\/\/www.olympiajournal.com\/news\/story\/611444\/the-global-transcatheter-embolization-and-occlusion-devices-market-size-is-projected-to-grow-at-a-cagr-of-93-during-the-forecast-period-from-2026-to-2034-delveinsight.html"},"modified":"2026-09-02T16:39:32","modified_gmt":"2026-09-02T16:39:32","slug":"the-global-transcatheter-embolization-and-occlusion-devices-market-size-is-projected-to-grow-at-a-cagr-of-93-during-the-forecast-period-from-2026-to-2034-delveinsight","status":"publish","type":"post","link":"https:\/\/www.olympiajournal.com\/news\/story\/611444\/the-global-transcatheter-embolization-and-occlusion-devices-market-size-is-projected-to-grow-at-a-cagr-of-93-during-the-forecast-period-from-2026-to-2034-delveinsight.html","title":{"rendered":"The Global Transcatheter Embolization and Occlusion Devices Market Size is projected to grow at a CAGR of 9.3% during the forecast period from 2026 to 2034 | DelveInsight"},"content":{"rendered":"<div style=\"font-style:italic;padding:8px 0px\">The Transcatheter Embolization and Occlusion Devices market is estimated at USD 5.62 billion in 2025 and is projected to reach USD 12.55 billion by 2034, growing at a CAGR of 9.3% during the forecast period from 2026 to 2034. North America is the largest market and Asia-Pacific is the fastest growing, with the market structure classified as moderately consolidated.<\/div>\n<p style=\"text-align: justify\"><strong>(Albany, New York) &#8211; 2nd Sep 2026 &#8211;<\/strong>&nbsp;DelveInsight&#8217;s Transcatheter Embolization and Occlusion Devices Market Insights Report 2034 provides current and forecast market analysis, individual leading Transcatheter Embolization and Occlusion Devices companies&#8217; market shares, challenges, Transcatheter Embolization and Occlusion Devices Market Drivers, barriers, trends, and key market Transcatheter Embolization and Occlusion Devices companies in the market.<\/p>\n<p style=\"text-align: justify\"><em><strong>To read more about the latest highlights related to the Transcatheter Embolization and Occlusion Devices Market @<a rel=\"nofollow\" href=\"https:\/\/www.delveinsight.com\/report-store\/transcatheter-embolization-and-occlusion-devices-market?utm_source=abnewswire&amp;utm_medium=pr&amp;utm_campaign=kkpr\"> https:\/\/www.delveinsight.com\/report-store\/transcatheter-embolization-and-occlusion-devices-market<\/a><\/strong><\/em><\/p>\n<p style=\"text-align: justify\"><strong>Key Takeaways from the Transcatheter Embolization and Occlusion Devices Market Report<\/strong><\/p>\n<ul style=\"text-align: justify\">\n<li>\n<p class=\"caps\"><strong>In January 2026, Boston Scientific Corporation<\/strong> announced a definitive agreement to acquire Penumbra, Inc. for approximately USD 14.5 billion in cash and stock, a deal expected to close in 2026. Strategic significance: Provides scaled entry into mechanical thrombectomy and neurovascular embolization and substantially expands Boston Scientific&#8217;s peripheral and neuro embolization portfolio.<\/p>\n<\/li>\n<li>\n<p><strong>In 2025, Stryker<\/strong> expanded its minimally invasive neurovascular treatment portfolio, building on its 2025 acquisition of Inari Medical for approximately USD 4.9 billion, which added pulmonary embolism and deep vein thrombosis devices. Strategic significance: Broadens Stryker&#8217;s vascular intervention and occlusion device portfolio.<\/p>\n<\/li>\n<li>\n<p><strong>In September 2025, Penumbra, Inc.<\/strong> launched the Ruby XL System, the largest and longest detachable embolization coil in its portfolio, alongside the Lightning Bolt 6X device. Strategic significance: Expands Penumbra&#8217;s coiled-device offering for complex, high-volume vascular occlusion procedures ahead of its pending acquisition by Boston Scientific.<\/p>\n<\/li>\n<li>\n<p>Growth is anchored in the rising global burden of cancer and expanding interventional oncology, the growing prevalence of vascular malformations and peripheral vascular disease, and the increasing integration of advanced imaging and AI-assisted navigation into embolization procedures.<\/p>\n<\/li>\n<li>\n<p>The leading Transcatheter Embolization and Occlusion Devices Companies include <em><strong>Boston Scientific Corporation, Medtronic, Penumbra, Inc., Cook, Edwards Lifesciences Corporation, Merit Medical Systems, Inc., Johnson &amp; Johnson Services, Inc., Lepu Medical Technology (Beijing) Co., Ltd, Kaneka Medix Corporation, and Stryker.<\/strong><\/em><\/p>\n<\/li>\n<\/ul>\n<p style=\"text-align: justify\"><em><strong>To know more about why North America is leading the market growth in the Transcatheter Embolization and Occlusion Devices Market, get a snapshot @<a rel=\"nofollow\" href=\"https:\/\/www.delveinsight.com\/report-store\/transcatheter-embolization-and-occlusion-devices-market?utm_source=abnewswire&amp;utm_medium=pr&amp;utm_campaign=kkpr\"> https:\/\/www.delveinsight.com\/report-store\/transcatheter-embolization-and-occlusion-devices-market<\/a><\/strong><\/em><\/p>\n<p style=\"text-align: justify\"><strong>Transcatheter Embolization and Occlusion Devices Overview <\/strong><\/p>\n<p style=\"text-align: justify\">Transcatheter embolization and occlusion devices are minimally invasive interventional tools &mdash; including coils, vascular plugs, embolization particles, and liquid embolic agents &mdash; deployed through a catheter to intentionally block or reduce blood flow within a targeted blood vessel. Guided by real-time fluoroscopic or cross-sectional imaging, these devices support the management of hemorrhage, aneurysms, arteriovenous malformations, uterine fibroids, and structural heart defects, and are integral to interventional oncology procedures such as transcatheter arterial chemoembolization (TACE) and radioembolization for liver, kidney, and lung tumors.<\/p>\n<p style=\"text-align: justify\"><strong>Transcatheter Embolization and Occlusion Devices Market Key Growth Drivers<\/strong><\/p>\n<ul style=\"text-align: justify\">\n<li>\n<p>The rising global burden of cancer, particularly liver, lung, kidney, and pancreatic cancers, is expanding demand for interventional oncology procedures such as TACE and radioembolization, with cancer diagnoses projected to reach approximately 32.5 million globally by 2045.<\/p>\n<\/li>\n<li>\n<p>The growing prevalence of vascular malformations, aneurysms, arteriovenous malformations, and gastrointestinal and pulmonary hemorrhage is expanding the addressable pool of patients requiring precise, catheter-based vascular occlusion.<\/p>\n<\/li>\n<li>\n<p>A structural shift toward minimally invasive procedures over open surgery &mdash; driven by reduced surgical trauma, shorter hospital stays, and faster recovery &mdash; is accelerating adoption of embolization and occlusion devices across hospitals and specialized clinics, particularly among elderly and high-risk patients.<\/p>\n<\/li>\n<li>\n<p>Integration of advanced imaging and navigation, including real-time fluoroscopy, three-dimensional imaging, and AI-assisted catheter guidance, is improving procedural precision and safety, encouraging wider clinical adoption.<\/p>\n<\/li>\n<li>\n<p>Continuous product innovation &mdash; including bioresorbable and drug-eluting embolic materials, next-generation detachable coil systems, and microcatheter-compatible vascular plugs &mdash; is broadening clinical applications, exemplified by Merit Medical&#8217;s Siege Vascular Plug and Instylla&#8217;s Embrace Hydrogel Embolic System, which received FDA premarket approval in 2025.<\/p>\n<\/li>\n<li>\n<p>Large-scale strategic consolidation is reshaping the competitive landscape, headlined by Boston Scientific&#8217;s approximately USD 14.5 billion agreement to acquire Penumbra, announced in January 2026, and Stryker&#8217;s USD 4.9 billion acquisition of Inari Medical in 2025.<\/p>\n<\/li>\n<\/ul>\n<p style=\"text-align: justify\"><em><strong>Get a sneak peek at the Transcatheter Embolization and Occlusion Devices Market Dynamics @<a rel=\"nofollow\" href=\"https:\/\/www.delveinsight.com\/report-store\/transcatheter-embolization-and-occlusion-devices-market?utm_source=abnewswire&amp;utm_medium=pr&amp;utm_campaign=kkpr\"> https:\/\/www.delveinsight.com\/report-store\/transcatheter-embolization-and-occlusion-devices-market<\/a><\/strong><\/em><\/p>\n<p style=\"text-align: justify\"><strong>Transcatheter Embolization and Occlusion Devices Market Segment Analysis <\/strong><\/p>\n<p style=\"text-align: justify\">The Transcatheter Embolization and Occlusion Devices market is segmented by Type (Coiled [Pushable Coils, Detachable Coils] and Non-Coiled [Flow Diverting Devices, Embolization Particles, Liquid Embolic, and Others]), Application (Peripheral Vascular Disease, Oncology, Neurology, Urology, and Others), End-User (Hospitals &amp; Clinics, Ambulatory Surgical Centers, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of World).<\/p>\n<p style=\"text-align: justify\">By Type, non-coiled devices led the market with a 51% share in 2025, offering precise vascular occlusion with predictable deployment for larger vessels, high-flow vascular malformations, and complex tumors, with reduced migration risk particularly valued in procedures such as TACE and uterine artery embolization.<\/p>\n<p style=\"text-align: justify\">By Application, oncology accounted for 45% of the market in 2025, given the central role of embolization in TACE and radioembolization procedures for liver, lung, kidney, and pancreatic tumors, where devices enable precise localized therapy delivery while limiting systemic toxicity.<\/p>\n<p style=\"text-align: justify\">By End-User, hospitals &amp; clinics held approximately 58% share in 2025, reflecting the comprehensive interventional radiology infrastructure, catheterization labs, and skilled healthcare professionals required for complex embolization procedures.<\/p>\n<p style=\"text-align: justify\"><em><strong>Which MedTech key players in the Transcatheter Embolization and Occlusion Devices Market are set to emerge as the trendsetter? Explore @<a rel=\"nofollow\" href=\"https:\/\/www.delveinsight.com\/report-store\/transcatheter-embolization-and-occlusion-devices-market?utm_source=abnewswire&amp;utm_medium=pr&amp;utm_campaign=kkpr\"> https:\/\/www.delveinsight.com\/report-store\/transcatheter-embolization-and-occlusion-devices-market<\/a><\/strong><\/em><\/p>\n<p style=\"text-align: justify\"><strong>Transcatheter Embolization and Occlusion Devices Market Competitive Landscape <\/strong><\/p>\n<p style=\"text-align: justify\">The Transcatheter Embolization and Occlusion Devices market is classified as Moderately Consolidated. A group of scaled, multinational players including Boston Scientific, Medtronic, Stryker, and Terumo anchor the top tier through broad product portfolios spanning coiled and non-coiled devices, while specialized providers such as Penumbra, Merit Medical, Cook, and Edwards Lifesciences compete through focused innovation in vascular plugs, embolization particles, and structural occlusion technologies. Large-scale consolidation, most notably Boston Scientific&#8217;s pending acquisition of Penumbra and Stryker&#8217;s acquisition of Inari Medical, is expected to further concentrate competitive scale among the market&#8217;s leading players.<\/p>\n<p style=\"text-align: justify\"><strong>Transcatheter Embolization and Occlusion Devices Companies <\/strong><\/p>\n<p style=\"text-align: justify\">Boston Scientific Corporation, Medtronic, Penumbra, Inc., Cook, Edwards Lifesciences Corporation, Merit Medical Systems, Inc., Johnson &amp; Johnson Services, Inc., Lepu Medical Technology (Beijing) Co., Ltd, Kaneka Medix Corporation, Stryker, and others.<\/p>\n<p style=\"text-align: justify\"><strong>Transcatheter Embolization and Occlusion Devices Market Restraints <\/strong><\/p>\n<p style=\"text-align: justify\">Despite strong underlying demand, the market faces material constraints. The risk of procedural complications, including infection, vessel injury, or inadvertent non-target embolization, can temper physician and patient confidence in certain settings. A shortage of highly skilled interventional radiologists and cardiologists in some regions constrains procedural volumes, while high device costs limit adoption in price-sensitive and emerging markets. U.S. tariffs on imported medical device components have further increased manufacturing costs, prompting some manufacturers to reconsider sourcing and production strategies, and reimbursement policy for newer embolic technologies remains uneven across geographies.<\/p>\n<p style=\"text-align: justify\"><em><strong>Interested in knowing where the Transcatheter Embolization and Occlusion Devices Market is heading by 2034? Click to get a snapshot of the Transcatheter Embolization and Occlusion Devices Market Trends &mdash;<a rel=\"nofollow\" href=\"https:\/\/www.delveinsight.com\/report-store\/transcatheter-embolization-and-occlusion-devices-market?utm_source=abnewswire&amp;utm_medium=pr&amp;utm_campaign=kkpr\"> https:\/\/www.delveinsight.com\/report-store\/transcatheter-embolization-and-occlusion-devices-market<\/a><\/strong><\/em><\/p>\n<p style=\"text-align: justify\"><strong>Scope of the Transcatheter Embolization and Occlusion Devices Market Report<\/strong><\/p>\n<ul style=\"text-align: justify\">\n<li>\n<p><strong>Coverage &ndash; Global<\/strong><\/p>\n<\/li>\n<li>\n<p><strong>Forecast Period &ndash;<\/strong> 2026&ndash;2034<\/p>\n<\/li>\n<li>\n<p><strong>Transcatheter Embolization and Occlusion Devices Companies<\/strong> &ndash; Boston Scientific Corporation, Medtronic, Penumbra, Inc., Cook, Edwards Lifesciences Corporation, Merit Medical Systems, Inc., Johnson &amp; Johnson Services, Inc., Lepu Medical Technology (Beijing) Co., Ltd, Kaneka Medix Corporation, Stryker<\/p>\n<\/li>\n<li>\n<p>Transcatheter Embolization and Occlusion Devices Market Restraints and Regulatory Analysis<\/p>\n<\/li>\n<li>\n<p>Transcatheter Embolization and Occlusion Devices Porter&#8217;s Five Forces Analysis and Market Assessment<\/p>\n<\/li>\n<\/ul>\n<p style=\"text-align: justify\"><em><strong>Explore more information on the Transcatheter Embolization and Occlusion Devices Market Insights @<a rel=\"nofollow\" href=\"https:\/\/www.delveinsight.com\/report-store\/transcatheter-embolization-and-occlusion-devices-market?utm_source=abnewswire&amp;utm_medium=pr&amp;utm_campaign=kkpr\"> https:\/\/www.delveinsight.com\/report-store\/transcatheter-embolization-and-occlusion-devices-market<\/a><\/strong><\/em><\/p>\n<p style=\"text-align: justify\"><strong>Table of Contents<\/strong><\/p>\n<ol style=\"text-align: justify\">\n<li>\n<p>Transcatheter Embolization and Occlusion Devices Market Report Introduction<\/p>\n<\/li>\n<li>\n<p>Transcatheter Embolization and Occlusion Devices Market Executive Summary<\/p>\n<\/li>\n<li>\n<p>Transcatheter Embolization and Occlusion Devices Market Key Factors Analysis<\/p>\n<\/li>\n<li>\n<p>Impact Analysis: AI, Geopolitical, Trade, and Economic Developments<\/p>\n<\/li>\n<li>\n<p>Regulatory Analysis<\/p>\n<\/li>\n<li>\n<p>Transcatheter Embolization and Occlusion Devices Market Porter&rsquo;s Five Forces Analysis<\/p>\n<\/li>\n<li>\n<p>Transcatheter Embolization and Occlusion Devices Market Assessment<\/p>\n<\/li>\n<li>\n<p>Transcatheter Embolization and Occlusion Devices Market Competitive Landscape<\/p>\n<\/li>\n<li>\n<p>Transcatheter Embolization and Occlusion Devices Market Startup Funding and Investment Trends<\/p>\n<\/li>\n<li>\n<p>Transcatheter Embolization and Occlusion Devices Market Company and Product Profiles<\/p>\n<\/li>\n<li>\n<p>KOL Views<\/p>\n<\/li>\n<li>\n<p>Project Approach<\/p>\n<\/li>\n<li>\n<p>About DelveInsight<\/p>\n<\/li>\n<li>\n<p>Disclaimer and Contact Us<\/p>\n<\/li>\n<\/ol>\n<p style=\"text-align: justify\"><strong>About Us<\/strong><\/p>\n<p style=\"text-align: justify\">DelveInsight is a leading healthcare-focused market research and consulting firm that provides clients with high-quality market intelligence and analysis to support informed business decisions. With a team of experienced industry experts and a deep understanding of the life sciences and healthcare sectors, we offer customized research solutions and insights to clients across the globe. Connect with us to get high-quality, accurate, and real-time intelligence to stay ahead of the growth curve.<\/p>\n<p><span style='font-size:18px !important'>Media Contact<\/span><br \/><strong>Company Name:<\/strong> <a rel=\"nofollow\" href=\"https:\/\/www.abnewswire.com\/companyname\/delveinsight.com_56431.html\">DelveInsight Business Research LLP<\/a><br \/><strong>Contact Person:<\/strong> Kanishk Kumar<br \/><strong>Email:<\/strong> <a rel=\"nofollow\" href=\"https:\/\/www.abnewswire.com\/email_contact_us.php?pr=the-global-transcatheter-embolization-and-occlusion-devices-market-size-is-projected-to-grow-at-a-cagr-of-93-during-the-forecast-period-from-2026-to-2034-delveinsight\">Send Email<\/a><br \/><strong>Phone:<\/strong> 09650213330<br \/><strong>Address:<\/strong>304 S. Jones Blvd #2432  <br \/><strong>City:<\/strong> Las Vegas<br \/><strong>State:<\/strong> Nevada<br \/><strong>Country:<\/strong> United States<br \/><strong>Website:<\/strong> <a rel=\"nofollow noopener\" href=\"https:\/\/www.delveinsight.com\/report-store\/transcatheter-embolization-and-occlusion-devices-market\" target=\"_blank\">https:\/\/www.delveinsight.com\/report-store\/transcatheter-embolization-and-occlusion-devices-market<\/a><\/p>\n<p><img decoding=\"async\" src=\"https:\/\/www.abnewswire.com\/press_stat.php?pr=the-global-transcatheter-embolization-and-occlusion-devices-market-size-is-projected-to-grow-at-a-cagr-of-93-during-the-forecast-period-from-2026-to-2034-delveinsight\" alt=\"\" width=\"1px\" height=\"1px\" \/><\/p>\n","protected":false},"excerpt":{"rendered":"<p>The Transcatheter Embolization and Occlusion Devices market is estimated at USD 5.62 billion in 2025 and is projected to reach USD 12.55 billion by 2034, growing at a CAGR of<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[],"_links":{"self":[{"href":"https:\/\/www.olympiajournal.com\/news\/wp-json\/wp\/v2\/posts\/611444"}],"collection":[{"href":"https:\/\/www.olympiajournal.com\/news\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.olympiajournal.com\/news\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.olympiajournal.com\/news\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.olympiajournal.com\/news\/wp-json\/wp\/v2\/comments?post=611444"}],"version-history":[{"count":0,"href":"https:\/\/www.olympiajournal.com\/news\/wp-json\/wp\/v2\/posts\/611444\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.olympiajournal.com\/news\/wp-json\/wp\/v2\/media?parent=611444"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.olympiajournal.com\/news\/wp-json\/wp\/v2\/categories?post=611444"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.olympiajournal.com\/news\/wp-json\/wp\/v2\/tags?post=611444"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}